ERBB2 and breast cancer: As shown in Figure 1, clear discriminations were obtained by ESI+ between BC and NC groups (Figure 1A), HER2-positive and HER2-negative BC groups (Figure 1B), ER-positive and ER-negative BC groups (Figure 1C).